Main Navigation

Quick Links

Recursion Pharmaceuticals Receives Grant by Bill & Melinda Gates Foundation

The grant, awarded by the Bill & Melinda Gates Foundation, represents a collaborative effort between Recursion and the Winzeler Lab at UC San Diego School of Medicine to accelerate the discovery of drugs to treat malaria, and sets the stage for Recursion to further broaden its drug discovery platform into infectious disease.

SALT LAKE CITY, UT — May 7, 2018 — Recursion Pharmaceuticals today announced the award of a $546,000 grant from the Bill & Melinda Gates Foundation to apply Recursion’s AI-enabled technology to the discovery of novel drugs with the ability to treat malaria.

Click here to read the full article.

Oh, hello!

Contact Form